New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Check below for free stories on AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
August 21, 2014
10:11 EDTTSMTaiwan expects to sell 177M shares of TSMC, Reuters reports
Subscribe for More Information
06:40 EDTMCDMcDonald's looking to expand digital efforts, CNBC says
Subscribe for More Information
August 20, 2014
12:58 EDTMCDMcDonald's temporarily closes certain Russian restaurants
The company said, "Based on a claim from a federal consumer agency, on Aug 20 2014, McDonald’s restaurants on Pushkin Square, Manezh Square and Prospect Mira were temporary closed. We are closely studying the subject of the documents to define what should be done to re-open the restaurants as soon as possible. Our main priority is to serve our customers with top quality menu items. We will continue taking care of our employees and will do our best to continue the success of McDonald’s business in Russia."
August 19, 2014
11:00 EDTMCDMcDonald's to unveil retail coffee initiative, Huffington Post says
Subscribe for More Information
06:02 EDTMCDTaco Bell introducing dollar menu, LA Times reports
Taco Bell (YUM) is introducing its new Dollar Cravings menu, which features 11 items, the LA Times reports. McDonald's (MCD) and Wendy's (WEN) both offer dollar menus. Reference Link
August 18, 2014
06:26 EDTMCDMcDonald's orders products from Thai supplier after food scare, Reuters says
Subscribe for More Information
August 17, 2014
13:40 EDTRHHBYChugai makes statement denying media reports on Roche deal
Subscribe for More Information
August 15, 2014
11:28 EDTRHHBYRoche in talks on $10B deal to buy remainder of Chugai, Bloomberg reports
Roche is in talks to purchase the 38% stake of Chugai Pharmaceutical that it doesn't already own, according to Bloomberg, citing people familiar with the matter. The potential deal is valued at approximately $10B. Though no financial decision has been made, the deal may be announced as early as next week, the sources added. Reference Link
11:02 EDTRHHBYRoche in talk on $10B deal to buy remainder of Chugai, Bloomberg says
Subscribe for More Information
06:39 EDTMCDTim Hortons aims to lure customers via new coffee launch, Reuters says
Tim Hortons (THI) is looking to attract new customers and fight competitors, such as Starbucks (SBUX) and McDonald's (MCD), by revealing a new dark roast coffee blend throughout North America while possibly increasing prices to fend-off increasing expenses and rivals, according to Reuters, citing comments from Tim Hortons CEO Marc Caira. Caira said, "Looking at the coffee market, I would suggest that, given the degree of cost increases, that we are looking at prices going up sometime in 2015." Reference Link
06:16 EDTTSMTSMC Q4 production capacity near fully booked, DigiTimes reports
TSMC has informed Taiwan-based IC design houses that its Q4 production capacity is almost fully booked, reports DigiTimes. According to industry sources, TSMC is urging vendors which are short of production capacity to book wafer orders in advance. Reference Link
06:12 EDTRHHBYGilead announced favorable ruling in arbitration against Roche
Gilead (GILD) announced that an arbitration panel determined that Roche (RHHBY) failed to establish any of their claims and ruled in favor of Gilead. As a result, Roche is not entitled to any damages or other relief. In March 2013, Roche initiated an arbitration against Gilead and Pharmasset, predecessor to Gilead Pharmasset, regarding a 2004 collaboration agreement between Roche and Pharmasset. In the arbitration demand, Roche asserted that it had an exclusive license to sofosbuvir pursuant to the collaboration agreement because sofosbuvir, a prodrug of a uridine monophosphate analog, is allegedly a prodrug of PSI-6130, a cytidine analog. Roche further claimed that, because it had exclusive rights to sofosbuvir, it also had an exclusive license to a patent covering sofosbuvir, and that we infringed that patent by selling and offering for sale products containing sofosbuvir.
August 14, 2014
16:02 EDTRHHBYFDA approves Genentech’s Avastin plus chemotherapy for cervical cancer treatment
Subscribe for More Information
09:11 EDTRHHBYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Kohl's (KSS), up 2.5%... Plug Power (PLUG), up 10%... Perrigo (PRGO), up 4.5%. HIGHER: Aruba Networks (ARUN), up 3% after shares upgraded at Stifel... KaloBios (KBIO), up 7.9% after publication shows EphA3 as target for anticancer therapy... Supernus (SUPN), up 4.4% after receiving FDA fast track designation for SPN-810. DOWN AFTER EARNINGS: Noodles & Company (NDLS), down 22%... Vipshop (VIPS), down 5.8%. LOWER: ExOne (XONE), down 10.7%, Voxeljet (VJET), down 6.6%, after earnings reports. Peers in the 3D space are lower as well, with Stratasys (SSYS) down 1% and 3D Systems (DDD) down 0.2%... Enphase Energy (ENPH), down 2.6% after filing to sell common stock for holders... InterMune (ITMN), down 3% after downgraded at Goldman following yesterday's advance on Bloomberg report that the company received takeover bids from Sanofi (SNY), Roche (RHHBY).
August 13, 2014
16:19 EDTRHHBYOn The Fly: Closing Wrap
Subscribe for More Information
13:13 EDTRHHBYInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
13:00 EDTRHHBYInterMune received takeover bids from Sanofi, Roche, Bloomberg says
06:16 EDTTSMIC vendors seeking wafer production at houses other than TSMC, DigiTimes says
More fabless IC vendors are seeking wafer production capacity at foundry houses other than TSMC (TSM) such as Samsung (SSNLF), Globalfoundries, United Microelectronics (UMC) and Semiconductor Manufacturing (SMI), reports DigiTimes. According to industry sources, the move to seek wafer production at other foundry houses is due to extremely tight productoin at TSMC where 8- and 12-inch wafers are currently fully booked. Reference Link
August 12, 2014
06:35 EDTAETManged Care recent pullback a buying opportunity, says Leerink
Subscribe for More Information
August 11, 2014
11:33 EDTMCDWorkday rises after reportedly winning record deal with McDonald's
Shares of cloud-based human capital management solution provider Workday (WDAY) are rising after the company is said to have won a deal with global fast food giant McDonald's (MCD) that would be the biggest in its history. WHAT'S NEW: JMP Securities analysts Patrick Walravens and Peter Lowry wrote in a note to investors this morning that the firm's checks indicate that Workday was awarded the human capital management business at McDonald’s, which the analysts said could be the biggest deal in the company’s history. The firm increased its estimate for Workday's Q2 billings to $185M from $182M, noting that both are above the company's guidance of $180M in billing for Q2. JMP maintains its Market Outperform rating and $126 price target on Workday, but the analysts noted that they like the stock over the longer-term, citing its market leading position in the Software-as-a-Service Enterprise Resource Planning space, which is set to triple from 2013 to 2020. PRICE ACTION: In late morning trading, shares of Workday gained $2.43, or 2.9%, to $86.34.
06:57 EDTATHNAvondale to hold a conference
Subscribe for More Information
06:49 EDTMCDWorkday won human capital business at McDonald's, says JMP Securities
JMP Securities says its due diligence indicates Workday (WDAY) won the human capital management business at McDonald's (MCD). JMP believes the contract could be the biggest deal in Workday's history and it raised its Q2 billings estimate to $185M from $182M. The firm keeps an Outperform rating on Workday with a $126 price target.
05:53 EDTRHHBYCuris shares look attractive, says Piper Jaffray
Subscribe for More Information
August 8, 2014
17:10 EDTMCDMarket finishes week up slightly as earnings offset by political events
Stocks finished the week fractionally higher than where they started as strong corporate earnings reports and better than expected economic data was weighed against concerns about geopolitical issues and negative M&A news. MACRO NEWS: A few ongoing geopolitical conflicts worried investors and weighed on shares. Russia unveiled sanctions against Western countries, banning the import of a wide range of food items from the U.S, the EU and a few allied countries in response to sanctions recently enacted against it from G7 nations... President Obama authorized the bombing of rebels in Iraq and Hamas and Israel failed to reach a permanent truce... An ISM services index, the U.S. trade deficit for June, and weekly jobless claims were all better than expected. Meanwhile, the increase in unit labor costs last quarter came in below the consensus outlook, perhaps easing fears that the Fed will need to raise interest rates sooner than expected. COMPANY NEWS: On the M&A front, two huge potential deals fell through as 21st Century Fox (FOX, FOXA) withdrew its offer to acquire Time Warner (TWX) and Sprint (S) reportedly decided to end its pursuit of a merger with peer T-Mobile (TMUS)... President Obama indicated that his administration would take unilateral steps in an effort to prevent companies from carrying out tax inversion acquisitions. Among the deals or possible transactions that involve inversion are Medtronic's (MDT) acquisition of Covidien (COV), Valeant's (VRX) proposed takeover of Allergan (AGN) and Mylan's (MYL) acquisition of Abbott's (ABT) developed markets branded generics pharmaceuticals business. Meanwhile, Walgreen's (WAG) stock tumbled after the U.S. company said it would not structure its takeover of European drugstore chain Alliance Boots as a tax inversion deal... 21st Century Fox, 3D printer maker Stratasys (SSYS), chip maker NVIDIA (NVDA), brewer Molson Coors (TAP), and luxury accessories maker Coach (COH) all rose following their earnings reports. Conversely, Target (TGT), luxury accessories maker Michael Kors (KORS) and Internet coupon provider Groupon (GRPN) fell following their results or guidance... Gannett (GCI) struck a deal to acquire the remaining 73% interest in Classified Ventures, whose primary asset is the online car shopping website Cars.com, for $1.8B from the other partners in the venture, which include McClatchy (MNI), Tribune Media (TRBAA), Graham Holdings (GHC) and A. H. Belo (AHC). Gannett also announced plans to spin-off its Publishing business, which includes USA Today, through a tax-free distribution to shareholders... McDonald's (MCD) stock was little changed after the company reported that its comparable store sales fell 2.5% in July, which was significantly worse than expected. Food quality issues weighed on the fast food company's sales in Asia and as a result of the China supplier issue, the company warned its previously issued global comparable sales forecast for 2014 is now at risk. INDEXES: The Dow finished the week up 0.35% to 16,553.93, the S&P 500 rose 0.32% to 1,931.59, and the Nasdaq gained 0.41% to 4,370.90.
16:28 EDTMCDOn The Fly: Closing Wrap
Stocks began the session in positive territory despite President Obama authorizing air strikes against the Islamic State militant group in northern Iraq in conjunction with a humanitarian effort. The early move higher stalled but the market then moved higher as reports confirmed that Russian military aircraft exercises near the Ukraine border had ended, as planned. ECONOMIC EVENTS: In the U.S., productivity growth rose 2.5% in the second quarter, beating expectations for a rise of 1.6%. Second quarter unit labor costs, however, only increased 0.6%, which was below the 1% consensus forecast. Wholesale inventories increased 0.3% in June, and sales were up 0.2%, which were both below expectations. COMPANY NEWS: Shares of McDonald's (MCD) were fractionally higher despite the company reporting that its comparable store sales fell 2.5% in July, which was significantly worse than expected. The fast food giant stated that its U.S. comparable sales were down 3.2% in the month compared to the same month of last year and that comp sales in Asia/Pacific, Middle East and Africa dropped 7.3%. The APMEA region's comparable sales decline reflects the impact of food quality and safety issues at a supplier to McDonald's and other food companies in China which caused a "significant negative impact" to results in China, Japan and certain other markets, the company noted. As a result of the China supplier issue, the company's previously issued global comparable sales forecast for 2014 is now at risk, McDonald's added. MAJOR MOVERS: Among the notable gainers was chip maker NVIDIA (NVDA), which rose $1.54, or 8.82%, to $19.00 after the company’s second quarter profit and third quarter revenue outlook surpassed analysts’ consensus estimates. Also higher was small-cap Tekmira Pharmaceuticals (TKMR), which jumped $6.43, or 45.06%, to $20.70 after announcing that the FDA has verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola Investigational New Drug Application to a partial clinical hold. Among the noteworthy losers was cereal maker Post Holdings (POST), which fell $7.08, or 15.91%, to $37.43 and was downgraded to Neutral from Buy at SunTrust after the company reported an adjusted net loss for its third quarter and agreed to acquire American Blanching Company for $128M. Also lower were shares of Ignite Restaurant (IRG), the owner of the Joe’s Crab Shack and Macaroni Grill brands, which fell $4.33, or 34.98%, to $8.05 after reporting second quarter results that missed analysts' expectations and having its shares downgraded at Raymond James and CL King. INDEXES: The Dow advanced 185.66, or 1.13%, to 16,553.93, the Nasdaq gained 35.93, or 0.83%, to 4,370.90, and the S&P 500 rose 22.02, or 1.15%, to 1,931.59.
12:34 EDTMCDOn The Fly: Midday Wrap
Subscribe for More Information
11:33 EDTRHHBYRoche submits supplemental Biologics License application to FDA for Lucentis
Subscribe for More Information
09:37 EDTMCDActive equity options trading on open
Subscribe for More Information
09:15 EDTMCDOn The Fly: Pre-market Movers
HIGHER: NVIDIA (NVDA), up 4.2%, upgraded at Needham following its better than expected Q2 results... Arista Networks (ANET), up 8%, upgraded at Citigroup following better than expected Q2 results, announcing an expanded strategic relationship with VMware (VMW)... Tekmira Pharmaceuticals (TKMR), up 17.5% after announcing that the FDA verbally confirmed they have modified the full clinical hold placed on its TKM-Ebola treatment to a partial clinical hold... Gap (GPS), up 4.7% after July same-store sales rose 2%, company issues Q2 EPS outlook above the consensus estimate... lululemon (LULU), up 2.4% after founder agrees to sell half his stake to Advent for $845M. UP AFTER EARNINGS: SolarCity (SCTY), up 1%... Assured Guaranty (AGO), up 9%... MercadoLibre (MELI), up 13.6%. LOWER: Zynga (ZNGA), down 6% after lowering fiscal 2014 guidance... McDonald's (MCD), down 0.4% after Chinese supplier issue contributes to July comparable sales drop of 2.5%.
08:34 EDTMCDMcDonald's warns 2014 comparable sales forecast at risk due to China issue
Subscribe for More Information
08:02 EDTMCDMcDonald's: AMPEA's sales reflect negative impact of food quality issues
Subscribe for More Information
07:58 EDTMCDMcDonald's rejports July global comparable sales down 2.5%
Subscribe for More Information
06:11 EDTMCDOSI withdraws products made in Shanghai in response to food scandal
After dealing with a food scandal, OSI China, parent company of Shanghai Husi Food, announced the withdrawal of products produced in Shanghai. The company said, "Husi is the subject of company and government investigations and it is proceeding smoothly. While there have been no reported illnesses linked to any Shanghai Husi products, recovering this production is an important step in facilitating the investigations and rebuilding the respect and trust of our customers, the government and the people of China. With assistances and guidance provided by Shanghai FDA, we have started the recovery process of products in question in a comprehensive and orderly." Worldwide brands such Yum! Brands (YUM) McDonald's (MCD) and Starbucks (SBUX) were affected by the scandal in China. Reference Link
August 7, 2014
14:06 EDTAETReinsurance Group names Tim Matson as Chief Investment Officer
Subscribe for More Information
14:05 EDTRHHBYPTC Therapeutics reports publication of preclinical study results in SMA models
PTC Therapeutics (PTCT) announced that he journal Science published results of a preclinical study demonstrating that treatment with orally available RNA splicing modifiers of the SMN2 gene starting early after birth is preventing deficits in mouse models of Spinal Muscular Atrophy or SMA. Stuart Peltz, CEO of PTC Therapeutics, said, "Using the experience and expertise in RNA biology we have gained at PTC over the last 16 years, we used our alternative splicing technology to identify and subsequently optimize investigational compounds that target the SMN2 splicing to produce the SMN protein. Our unique partnership with Roche and the SMA Foundation has allowed this project to rapidly move into clinical development." Luca Santarelli, Head of Neuroscience, Ophthalmology and Rare Diseases at Roche (RHHBY), said, "Although still preclinical, these results demonstrate how SMN2 splicing modifiers could correct the molecular deficit that causes SMA. This study represents an important step towards developing a potential therapeutic option for this devastating and currently untreatable condition. Early clinical trials are currently underway to determine the safety and tolerability of this approach."
13:23 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
12:29 EDTAETHealth insurers fall after two downgrades from Goldman
Shares of a number of health insurers are falling after Goldman Sachs downgraded its rating on one stock in the sector and removed another from its Conviction List. WHAT'S NEW: Goldman analyst Matthew Borsch downgraded his rating on Aetna (AET) to Neutral from Buy and removed UnitedHealth (UNH) from the firm's Conviction List, as he believes that other stocks in the healthcare sector are more attractive. Utilization of healthcare services by individuals who don't have the Affordable Care Act is likely to show signs of increasing by 2015, posing a "manageable" challenge to health insurers, Borsch wrote. However, the increase in the utilization of these services is likely to be "relatively gradual" compared with similar trends in the past, the analyst contended. Borsch based his forecast on healthcare spending trends during previous economic recoveries. He reduced his 2015 earnings estimate for Aetna to $7 from $7.10 and for United Health to $5.95 from $6. He reduced his 2015 EPS estimates for other companies in the sector, as his earnings outlook for WellPoint (WLP) declined to $9.20 from $9.35, while his estimate for Cigna (CI) for next year dropped to $7.90 from $8. The analyst kept Neutral ratings on both WellPoint and Cigna. Meanwhile, Borsch cut his price target on Aetna to $88 from $91 and on UnitedHealth to $91 from $96. PRICE ACTION: In early afternoon trading, Aetna fell 3% to $76, UnitedHealth slumped 2.5% to $79.50, WellPoint declined 2.5% to $108, and Cigna retreated 2.5% to $89.
10:00 EDTAETOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:08 EDTMPELOn The Fly: Pre-market Movers
Subscribe for More Information
08:58 EDTMPELMelco Crown announces $500M share repurchase program
Subscribe for More Information
08:58 EDTMPELMelco Crown reports Taiwan branch office indicted for alleged banking violations
Subscribe for More Information
08:25 EDTMPELMelco Crown reports Q2 EPS 26c, consensus 36c
Reports Q2 revenue $1.19B, consensus $1.3B.
05:41 EDTAETAetna downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Aetna to Neutral citing less favorable sector trends. The firm lowered its price target for shares to $88 from $91.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use